3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 25 0 1 0 0 0 0 0999 V2000
3.4456 0.6372 0.2118 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7229 -1.6348 0.3347 O 0 0 0 0 0 0 0 0 0 0 0 0
1.6263 -0.6643 0.0577 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1065 0.6659 0.1045 C 0 0 2 0 0 0 0 0 0 0 0 0
-0.0046 0.9113 -0.8971 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3488 1.4945 -0.1502 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3281 0.3703 -0.4174 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9958 -0.6598 0.2078 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6840 -0.9332 -0.7289 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1674 1.1854 0.3270 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9083 -1.4334 -0.2853 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3915 0.6851 0.7707 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7620 -0.6243 0.4646 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7653 0.8327 1.1342 H 0 0 0 0 0 0 0 0 0 0 0 0
0.2405 0.4774 -1.8757 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.1165 1.9898 -1.0720 H 0 0 0 0 0 0 0 0 0 0 0 0
2.4740 1.7741 -1.2021 H 0 0 0 0 0 0 0 0 0 0 0 0
2.3723 2.4008 0.4624 H 0 0 0 0 0 0 0 0 0 0 0 0
1.0627 -1.5077 0.0974 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.0283 -1.5714 -1.3142 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.8873 2.2058 0.5729 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.1971 -2.4528 -0.5241 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.0560 1.3149 1.3551 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.7152 -1.0140 0.8101 H 0 0 0 0 0 0 0 0 0 0 0 0
1 6 1 0 0 0 0
1 8 1 0 0 0 0
2 8 2 0 0 0 0
3 4 1 0 0 0 0
3 8 1 0 0 0 0
3 19 1 0 0 0 0
4 5 1 0 0 0 0
4 6 1 0 0 0 0
4 14 1 0 0 0 0
5 7 1 0 0 0 0
5 15 1 0 0 0 0
5 16 1 0 0 0 0
6 17 1 0 0 0 0
6 18 1 0 0 0 0
7 9 2 0 0 0 0
7 10 1 0 0 0 0
9 11 1 0 0 0 0
9 20 1 0 0 0 0
10 12 2 0 0 0 0
10 21 1 0 0 0 0
11 13 2 0 0 0 0
11 22 1 0 0 0 0
12 13 1 0 0 0 0
12 23 1 0 0 0 0
13 24 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
(4R)-4-benzyl-1,3-oxazolidin-2-one
4.2 InChl
InChI=1S/C10H11NO2/c12-10-11-9(7-13-10)6-8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H,11,12)/t9-/m1/s1
4.3 InChlKey
OJOFMLDBXPDXLQ-SECBINFHSA-N
4.4 Canonical SMILES
C1C(NC(=O)O1)CC2=CC=CC=C2
4.5 lsomeric SMILES
C1[C@H](NC(=O)O1)CC2=CC=CC=C2
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病